Back to results
US 2026/0076991 A1Published application
Hyaluronic Acid Nanoparticles Comprising NADPH Oxidases Inhibitors and Uses in Treating Cancer
AssigneeEmory University
InventorsLily Yang, Lei Zhu
Life of this patent
Estimating the term…
Abstract
This disclosure relates to hyaluronic acid nanoparticles containing an anticancer agent such as a NADPH oxidase (NOX) inhibitor for targeted delivery to cancerous cells or tumors. In certain embodiments, the nanoparticles are made up of hyaluronic acid conjugated to hydrophobic moieties. In certain embodiments, the hydrophobic moieties are steroid based compounds, such as 5beta-cholanic acid.
Claims19
A nanoparticle comprising 50-cholanic acid conjugated to hyaluronic acid and 2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1,2-dihydro-3H-pyrazolo[4,3-c]pyridine-3,6(5H)-dione or salt thereof.
Dependencies are inferred from the claim text.